Cargando…

Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!

Transfection by means of non-viral gene delivery vectors is the cornerstone of modern gene delivery. Despite the resources poured into the development of ever more effective transfectants, improvement is still slow and limited. Of note, the performance of any gene delivery vector in vitro is strictl...

Descripción completa

Detalles Bibliográficos
Autores principales: Bono, Nina, Ponti, Federica, Mantovani, Diego, Candiani, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076396/
https://www.ncbi.nlm.nih.gov/pubmed/32098191
http://dx.doi.org/10.3390/pharmaceutics12020183
_version_ 1783507206948257792
author Bono, Nina
Ponti, Federica
Mantovani, Diego
Candiani, Gabriele
author_facet Bono, Nina
Ponti, Federica
Mantovani, Diego
Candiani, Gabriele
author_sort Bono, Nina
collection PubMed
description Transfection by means of non-viral gene delivery vectors is the cornerstone of modern gene delivery. Despite the resources poured into the development of ever more effective transfectants, improvement is still slow and limited. Of note, the performance of any gene delivery vector in vitro is strictly dependent on several experimental conditions specific to each laboratory. The lack of standard tests has thus largely contributed to the flood of inconsistent data underpinning the reproducibility crisis. A way researchers seek to address this issue is by gauging the effectiveness of newly synthesized gene delivery vectors with respect to benchmarks of seemingly well-known behavior. However, the performance of such reference molecules is also affected by the testing conditions. This survey points to non-standardized transfection settings and limited information on variables deemed relevant in this context as the major cause of such misalignments. This review provides a catalog of conditions optimized for the gold standard and internal reference, 25 kDa polyethyleneimine, that can be profitably replicated across studies for the sake of comparison. Overall, we wish to pave the way for the implementation of standardized protocols in order to make the evaluation of the effectiveness of transfectants as unbiased as possible.
format Online
Article
Text
id pubmed-7076396
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70763962020-03-24 Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar! Bono, Nina Ponti, Federica Mantovani, Diego Candiani, Gabriele Pharmaceutics Review Transfection by means of non-viral gene delivery vectors is the cornerstone of modern gene delivery. Despite the resources poured into the development of ever more effective transfectants, improvement is still slow and limited. Of note, the performance of any gene delivery vector in vitro is strictly dependent on several experimental conditions specific to each laboratory. The lack of standard tests has thus largely contributed to the flood of inconsistent data underpinning the reproducibility crisis. A way researchers seek to address this issue is by gauging the effectiveness of newly synthesized gene delivery vectors with respect to benchmarks of seemingly well-known behavior. However, the performance of such reference molecules is also affected by the testing conditions. This survey points to non-standardized transfection settings and limited information on variables deemed relevant in this context as the major cause of such misalignments. This review provides a catalog of conditions optimized for the gold standard and internal reference, 25 kDa polyethyleneimine, that can be profitably replicated across studies for the sake of comparison. Overall, we wish to pave the way for the implementation of standardized protocols in order to make the evaluation of the effectiveness of transfectants as unbiased as possible. MDPI 2020-02-21 /pmc/articles/PMC7076396/ /pubmed/32098191 http://dx.doi.org/10.3390/pharmaceutics12020183 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bono, Nina
Ponti, Federica
Mantovani, Diego
Candiani, Gabriele
Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
title Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
title_full Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
title_fullStr Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
title_full_unstemmed Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
title_short Non-Viral in Vitro Gene Delivery: It is Now Time to Set the Bar!
title_sort non-viral in vitro gene delivery: it is now time to set the bar!
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076396/
https://www.ncbi.nlm.nih.gov/pubmed/32098191
http://dx.doi.org/10.3390/pharmaceutics12020183
work_keys_str_mv AT bononina nonviralinvitrogenedeliveryitisnowtimetosetthebar
AT pontifederica nonviralinvitrogenedeliveryitisnowtimetosetthebar
AT mantovanidiego nonviralinvitrogenedeliveryitisnowtimetosetthebar
AT candianigabriele nonviralinvitrogenedeliveryitisnowtimetosetthebar